PALI — Palisade Bio, Inc. | XLV Holdings | StockAdder

(PALI)

Palisade Bio, Inc.

Live chart and latest PALI stock news.

Sector ETF → XLV Health Care Select

Chart powered byTradingView— professional charts for every trader.Try it free →

PALI News

Piper Sandler reiterates Overweight rating on Palisade Bio stock

Apr 13, 2026 MSN

Here's Why Palisade Bio (PALI) Could be Great Choice for a Bottom Fisher

Apr 13, 2026 Stock Titan

Palisade Bio CEO, CMO to give virtual Needham presentation April 16

Apr 8, 2026 Yahoo Finance

Individual investors are Palisade Bio, Inc.'s (NASDAQ:PALI) biggest owners and were rewarded after market cap rose by US$70m last week

Nov 21, 2025 Seeking Alpha

Palisade Bio: Undervalued Biotech With Blockbuster Potential, Initiating With A Speculative Buy Rating

Mar 23, 2026 Quiver Quantitative

Palisade Bio, Inc. Announces Pricing of Public Offering of Common Stock Expected to Raise Approximately $120 Million

Oct 1, 2025 Investing.com

Palisade Bio stock maintains buy rating at Stifel on trial data

Mar 31, 2026 Stock Titan

Palisade Bio (NASDAQ: PALI) sells 1.54M shares to Iterative Health affiliate

Apr 2, 2026 Yahoo Finance

Palisade Bio (PALI) Reports Positive Phase 1b Data for PALI-2108 in UC Patients

Mar 18, 2026 Investing.com

Palisade Bio enters agreement with Iterative Health and completes $3 million stock sale

Apr 2, 2026 Stock Titan

$120 Million Stock Offering: Biotech Palisade Bio Prices Massive 171.4M Share Public Offering at $0.70

Oct 1, 2025 Yahoo Finance

Palisade Bio (PALI) Soars 5% Ahead of Clinical Trial Results

Dec 25, 2025 Stock Titan

After 2 weeks, Palisade’s Crohn’s pill showed no serious side effects

Mar 30, 2026 Yahoo Finance

All You Need to Know About Palisade Bio (PALI) Rating Upgrade to Buy

Nov 6, 2025 Yahoo Finance

Palisade Bio (PALI) Upgraded to Buy: Here's What You Should Know